Cutaneous hyperpigmentation following bleomycin sclerotherapy for vascular malformations
Sign Up to like & getrecommendations! Published in 2021 at "Pediatric Dermatology"
DOI: 10.1111/pde.14869
Abstract: Systemic bleomycin therapy is associated with pulmonary fibrosis and cutaneous side effects. While it is believed that there is little to no systemic distribution of bleomycin when utilized to treat vascular malformations (VMs), we present… read more here.
Keywords: cutaneous hyperpigmentation; vascular malformations; hyperpigmentation following; bleomycin ... See more keywords